Albuterol Sulfate HFA Inhalation Aerosol
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Albuterol Sulfate HFA Inhalation Aerosol, covering 2010-12-10 to 2024-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd [Phase 3]